Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
At baseline, with the exception of total daily vitamin E intake and the percentage of vitamin E supplement users, no differences were observed among the study groups with respect to age, smoking status, body mass index, systolic and diastolic blood pressure, plasma levels of 25-hydroxyvitamin D, plasma levels of LH, follicle-stimulating hormone (FSH), thyroid-stimulating hormone (TSH) and free thyroxine, or daily dietary intake of macro: and micronutrients (Table 1).
Source: 2. Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Participants were men aged 40 to 75 years diagnosed with LOH.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The Impact of Vitamin E Intake on Cardiometabolic Outcomes of Testosterone Replacement Therapy in Men with Late-Onset Hypogonadism
Study design awaiting verification · International Journal of Molecular Sciences · 2026
Original publication title
The Impact of Vitamin E Intake on Cardiometabolic Outcomes of Testosterone Replacement Therapy in Men with Late-Onset Hypogonadism
© 2026 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Androgen deficiency is associated with an increased risk of cardiometabolic complications, whereas vitamin E may exert protective effects against cardiovascular and metabolic diseases. This pilot prospective cohort study examined whether cardiometabolic outcomes observed during exogenous testosterone therapy differed according to vitamin E intake in men with insufficient endogenous testosterone production. Three cohorts of men with late-onset hypogonadism (LOH) (n = 29 per group), matched for age, smoking status, body mass index, and baseline testosterone concentration, were classified according to vitamin E intake as low, adequate, or high; 29 men without LOH served as controls.
Men with LOH received intramuscular testosterone injections every three weeks for six months. Cardiometabolic parameters were assessed before and after treatment, including biochemical markers, carotid intima: media thickness, retinal vascular sclerotic changes, and estimated 10-year cardiovascular risk. Compared with controls, men with LOH had higher HOMA-IR, LDL cholesterol, uric acid, fibrinogen, homocysteine, high-sensitivity C-reactive protein (hsCRP), urinary albumin-to-creatinine ratio (UACR), carotid intima: media thickness, and estimated 10-year cardiovascular risk. Elevations in homocysteine, hsCRP, and UACR were more pronounced in men with low or high vitamin E intake than in those with adequate intake.
Testosterone levels increased during treatment in all groups. Improvements were observed in most cardiometabolic parameters in men with adequate vitamin E intake, whereas changes were limited to HOMA-IR in those with low intake. In men with high intake, no significant changes were observed except for a decrease in HDL cholesterol. At study completion, carotid intima: media thickness and retinal vascular sclerotic changes in men with adequate vitamin E intake did not differ significantly from those in controls. Changes in assessed risk factors correlated with increases in testosterone levels and mean daily vitamin E intake.
These findings suggest an association between vitamin E intake and cardiometabolic outcomes observed during testosterone therapy in men with testosterone deficiency.
Authors’ abstract
Androgen deficiency is associated with an increased risk of cardiometabolic complications, whereas vitamin E may exert protective effects against cardiovascular and metabolic diseases. This pilot prospective cohort study examined whether cardiometabolic outcomes observed during exogenous testosterone therapy differed according to vitamin E intake in men with insufficient endogenous testosterone production. Three cohorts of men with late-onset hypogonadism (LOH) (n = 29 per group), matched for age, smoking status, body mass index, and baseline testosterone concentration, were classified according to vitamin E intake as low, adequate, or high; 29 men without LOH served as controls.
Men with LOH received intramuscular testosterone injections every three weeks for six months. Cardiometabolic parameters were assessed before and after treatment, including biochemical markers, carotid intima: media thickness, retinal vascular sclerotic changes, and estimated 10-year cardiovascular risk. Compared with controls, men with LOH had higher HOMA-IR, LDL cholesterol, uric acid, fibrinogen, homocysteine, high-sensitivity C-reactive protein (hsCRP), urinary albumin-to-creatinine ratio (UACR), carotid intima: media thickness, and estimated 10-year cardiovascular risk. Elevations in homocysteine, hsCRP, and UACR were more pronounced in men with low or high vitamin E intake than in those with adequate intake.
Testosterone levels increased during treatment in all groups. Improvements were observed in most cardiometabolic parameters in men with adequate vitamin E intake, whereas changes were limited to HOMA-IR in those with low intake. In men with high intake, no significant changes were observed except for a decrease in HDL cholesterol. At study completion, carotid intima: media thickness and retinal vascular sclerotic changes in men with adequate vitamin E intake did not differ significantly from those in controls. Changes in assessed risk factors correlated with increases in testosterone levels and mean daily vitamin E intake.
These findings suggest an association between vitamin E intake and cardiometabolic outcomes observed during testosterone therapy in men with testosterone deficiency.
Publication and source details
Original title: The Impact of Vitamin E Intake on Cardiometabolic Outcomes of Testosterone Replacement Therapy in Men with Late-Onset Hypogonadism
Robert Krysiak; Witold Szkróbka; Karolina Kowalcze; Grzegorz Machnik; Karolina Zapletal-Pudełko; Bogusław Okopień
International Journal of Molecular Sciences · 2026
* Correspondence: rkrysiak@sum.edu.pl; Tel./Fax: +48-32-252-3902© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:31:15.173151+00:00
DOI: 10.3390/ijms27208953 · PMC13704612